Company registration number 12484459 (England and Wales)
JEVALEX LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2022
PAGES FOR FILING WITH REGISTRAR
JEVALEX LIMITED
COMPANY INFORMATION
Directors
A Jakobi
J Vergne
Company number
12484459
Registered office
13A Downshire Hill
London
NW3 1NR
Accountants
Grunberg & Co Limited
5 Technology Park
Colindeep Lane
Colindale
London
United Kingdom
NW9 6BX
JEVALEX LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 4
JEVALEX LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
28 FEBRUARY 2022
28 February 2022
- 1 -
2022
2021
Notes
£
£
£
£
Current assets
Stocks
23,429
19,000
Debtors
3
36,365
22,740
Cash at bank and in hand
13,257
257,093
73,051
298,833
Creditors: amounts falling due within one year
4
(55,585)
(84,362)
Net current assets
17,466
214,471
Capital and reserves
Called up share capital
171,355
171,355
Share premium account
118,089
118,089
Equity reserve
394,983
280,000
Profit and loss reserves
(666,961)
(354,973)
Total equity
17,466
214,471

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial Year ended 28 February 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the Year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 September 2022 and are signed on its behalf by:
A Jakobi
Director
Company Registration No. 12484459
JEVALEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2022
- 2 -
1
Accounting policies
Company information

Jevalex Limited is a private company limited by shares incorporated in England and Wales. The registered office is 13A Downshire Hill, London, NW3 1NR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

The accounts have been prepared on a going concern basis, as the company will receive the continued support of its directors and shareholders for a period in excess of twelve months from the date of approval of these financial statements.

1.3
Turnover

Turnover represents net invoiced sale of goods, excluding value added tax. Turnover is recognised at the point of sale.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Stocks

Stocks are valued at the lower of cost and estimated selling price less costs to sell, based on weighted average cost, after making due allowance for obsolete and slow moving items.

 

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is

reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

JEVALEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2022
1
Accounting policies
(Continued)
- 3 -
1.6
Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of financial asset and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

 

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

 

Debtors

 

Basic financial assets, including trade and other debtors are measured at transaction price, less any impairment.

 

Cash and cash equivalents

 

Cash and cash equivalents represented by cash in hand and deposits held at call with financial institutions, are measured at amortised cost.

 

Creditors

 

Basic financial liabilities, including trade and other creditors, are recognised at transaction price.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

JEVALEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2022
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the Year was:

2022
2021
Number
Number
Total
2
2
3
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
12,873
-
0
Corporation tax recoverable
20,477
-
0
Other debtors
1,606
21,042
Prepayments and accrued income
1,409
1,698
36,365
22,740
4
Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
20,234
83,362
Amounts owed to related companies
35,351
-
0
Accruals and deferred income
-
0
1,000
55,585
84,362
2022-02-282021-03-01false08 September 2022CCH SoftwareCCH Accounts Production 2022.200No description of principal activityA JakobiJ Vergne124844592021-03-012022-02-2812484459bus:Director12021-03-012022-02-2812484459bus:Director22021-03-012022-02-2812484459bus:RegisteredOffice2021-03-012022-02-28124844592022-02-28124844592021-02-2812484459core:CurrentFinancialInstrumentscore:WithinOneYear2022-02-2812484459core:CurrentFinancialInstrumentscore:WithinOneYear2021-02-2812484459core:ShareCapital2022-02-2812484459core:ShareCapital2021-02-2812484459core:SharePremium2022-02-2812484459core:SharePremium2021-02-2812484459core:OtherReservesSubtotal2022-02-2812484459core:OtherReservesSubtotal2021-02-2812484459core:RetainedEarningsAccumulatedLosses2022-02-2812484459core:RetainedEarningsAccumulatedLosses2021-02-28124844592020-02-262021-02-2812484459core:CurrentFinancialInstruments2022-02-2812484459core:CurrentFinancialInstruments2021-02-2812484459bus:PrivateLimitedCompanyLtd2021-03-012022-02-2812484459bus:SmallCompaniesRegimeForAccounts2021-03-012022-02-2812484459bus:FRS1022021-03-012022-02-2812484459bus:AuditExempt-NoAccountantsReport2021-03-012022-02-2812484459bus:FullAccounts2021-03-012022-02-28xbrli:purexbrli:sharesiso4217:GBP